Therapeutic effects of anti‐GM2 CAR‐T cells expressing IL‐7 and CCL19 for GM2‐positive solid cancer in xenograft model
Abstract Background While chimeric antigen receptor (CAR)‐T cell therapy has demonstrated excellent efficacy in hematopoietic malignancies, its clinical application in solid cancers has yet to be achieved. One of the reasons for such hurdle is a lack of suitable CAR targets in solid cancers. Methods...
Main Authors: | Takahiro Sasaki, Yukimi Sakoda, Keishi Adachi, Yoshihiro Tokunaga, Koji Tamada |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5907 |
Similar Items
-
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
by: Elisabetta Cribioli, et al.
Published: (2022-08-01) -
223 CAR-T cells expressing both IL-7 and CCL19 induce epitope spreading via cross presentation of endogenous tumor antigens
by: Keishi Adachi, et al.
Published: (2023-11-01) -
Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
by: Natalie M. Deschenes, et al.
Published: (2023-05-01) -
Disordered testosterone transport in mice lacking the ganglioside GM2/GD2 synthase gene
by: Koichi Furukawa, et al.
Published: (2023-09-01) -
Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?
by: Samar K. Alselehdar, et al.
Published: (2021-10-01)